ConductScience.org, home

Paper4562008

Immunospecific regression of methylcholanthrene fibrosarcoma using neuraminidase. 3. Synergistic effect of BCG and neuraminidase treated tumor cells.

Simmons RL and 1 other. Ann Surg, 1972. Cited by 27 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Immunospecific regression of methylcholanthrene fibrosarcoma using neuraminidase. 3. Synergistic effect of BCG and neuraminidase treated tumor cells. Papers, record 4562008. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4562008

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immunospecific regression of methylcholanthrene fibrosarcoma using neuraminidase. 3. Synergistic effect of BCG and neuraminidase treated tumor cells.
PubMed
Journal
Ann Surg
PubMed
Year
1972
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
0.98
iCite
Revised in PubMed
2019-05-14
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Simmons RLR L
2Rios AA

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BCG VaccineMajor topic
FibrosarcomaMajor topic
NeuraminidaseMajor topic
Transplantation ImmunologyMajor topic
Animals
Antibody Specificity
Cells, Cultured
Female
Hindlimb
Methylcholanthrene
Mice
Mice, Inbred Strains
Mitomycins
Mycobacterium bovis
Neoplasm Transplantation
Sarcoma, Experimental
Transplantation, Homologous
Vibrio cholerae

Source PubMed

Download CSV of topics

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15920360The effect of neuraminidase on the phagocytic process in human monocytes.Lab Invest1966https://conductscience.org/library/papers/5920360PubMed
25656653Immunogenicity of L 1210 murine leukaemia cells after treatment with neuraminidase.Nature1968https://conductscience.org/library/papers/5656653PubMed
34875696Effect of neuraminidase on the phagocytosis of heterologous red cells by mouse peritoneal macrophages.Proc Soc Exp Biol Med1968https://conductscience.org/library/papers/4875696PubMed
45705148The role of sialic acid in antigenic expression: further studies of the Landschütz ascites tumour.Br J Cancer1968https://conductscience.org/library/papers/5705148PubMed
55766942The effect of neuraminidase on the fate of transfused lymphocytes.J Exp Med1969https://conductscience.org/library/papers/5766942PubMed
65768430Tumour specific immunogenicity of methylcholanthrene-induced sarcoma cells after incubation in neuraminidase.Br J Cancer1969https://conductscience.org/library/papers/5768430PubMed
74182654Active immunotherapy for acute lymphoblastic leukaemia.Lancet1969https://conductscience.org/library/papers/4182654PubMed
84312660Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells.Br J Cancer1969https://conductscience.org/library/papers/4312660PubMed
95272336Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy.Ann Surg1970https://conductscience.org/library/papers/5272336PubMed
104323415Immunotherapy of cancer: regression of tumors after intralesional injection of living Mycobacterium bovis.Science1971https://conductscience.org/library/papers/4323415PubMed
115576331Antigenic specificities on murine sarcoma cells. Reciprocal relationship between normal transplantation antigens (H-2) and tumor-specific immunogenicity.J Exp Med1971https://conductscience.org/library/papers/5576331PubMed
124931975Failure of neuraminidase to unmask histocompatibility antigens on trophoblast.Nat New Biol1971https://conductscience.org/library/papers/4931975PubMed
134931977Immunogenicity and antigenicity of lymphoid cells treated with neuraminidase.Nat New Biol1971https://conductscience.org/library/papers/4931977PubMed
145088046Blood-group isoantigens in leukemic cells: reversibility of isoantigenic changes by neuraminidase.J Natl Cancer Inst1971https://conductscience.org/library/papers/5088046PubMed
155092115Immunospecific regression of methylcholanthrene fibrosarcoma with the use of neuraminidase.Surgery1971https://conductscience.org/library/papers/5092115PubMed
164106346Effect of neuraminidase on serological properties of murine lymphoid cells.Transplant Proc1971https://conductscience.org/library/papers/4106346PubMed
174107297Immunologic approach to cancer.Transplant Proc1970https://conductscience.org/library/papers/4107297PubMed
185118473Failure of neuraminidase to unmask allogeneic antigens on cell surfaces.Proc Soc Exp Biol Med1971https://conductscience.org/library/papers/5118473PubMed
194399183Modification of graft-versus-host disease by neuraminidase treatment of donor cells. Decreased tolerogenicity of neuraminidase-treated cells.Transplantation1971https://conductscience.org/library/papers/4399183PubMed
204550256Comparative effect of Mycobacterium bovis- and neuraminidase-treated tumor cells on the growth of established methylcholanthrene fibrosarcomas in syngeneic mice.Cancer Res1972https://conductscience.org/library/papers/4550256PubMed

See all 25 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
1130852Antitumor immune response following injection of neuraminidase-treated sarcoma cells.Ann Surg1975https://conductscience.org/library/papers/1130852PubMed
793085Immunology of bronchial carcinoma.Thorax1976https://conductscience.org/library/papers/793085PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
NEU14758PubTator's text mininghttps://conductscience.org/library/genes/4758

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4562008

GET https://conductscience.org/api/papers/v1/4562008/references?page=2